List of Tables
Table 1. Targeted Radionuclide Drug Market Trends
Table 2. Targeted Radionuclide Drug Market Drivers & Opportunity
Table 3. Targeted Radionuclide Drug Market Challenges
Table 4. Targeted Radionuclide Drug Market Restraints
Table 5. Global Targeted Radionuclide Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Targeted Radionuclide Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Targeted Radionuclide Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Targeted Radionuclide Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Targeted Radionuclide Drug
Table 10. Global Targeted Radionuclide Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Targeted Radionuclide Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Targeted Radionuclide Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Targeted Radionuclide Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Targeted Radionuclide Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Targeted Radionuclide Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Targeted Radionuclide Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Targeted Radionuclide Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Targeted Radionuclide Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Targeted Radionuclide Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Targeted Radionuclide Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Targeted Radionuclide Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Targeted Radionuclide Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Targeted Radionuclide Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Targeted Radionuclide Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Targeted Radionuclide Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Targeted Radionuclide Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Targeted Radionuclide Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Targeted Radionuclide Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. POINT Biopharma Basic Information List
Table 32. POINT Biopharma Description and Business Overview
Table 33. POINT Biopharma Targeted Radionuclide Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Targeted Radionuclide Drug Business of POINT Biopharma (2019-2024)
Table 35. POINT Biopharma Recent Developments
Table 36. Telix Basic Information List
Table 37. Telix Description and Business Overview
Table 38. Telix Targeted Radionuclide Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Telix (2019-2024)
Table 40. Telix Recent Developments
Table 41. ITM AG Basic Information List
Table 42. ITM AG Description and Business Overview
Table 43. ITM AG Targeted Radionuclide Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Targeted Radionuclide Drug Business of ITM AG (2019-2024)
Table 45. ITM AG Recent Developments
Table 46. Bayer AG Basic Information List
Table 47. Bayer AG Description and Business Overview
Table 48. Bayer AG Targeted Radionuclide Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Bayer AG (2019-2024)
Table 50. Bayer AG Recent Developments
Table 51. Novartis Basic Information List
Table 52. Novartis Description and Business Overview
Table 53. Novartis Targeted Radionuclide Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Novartis (2019-2024)
Table 55. Novartis Recent Developments
Table 56. Lantheus Basic Information List
Table 57. Lantheus Description and Business Overview
Table 58. Lantheus Targeted Radionuclide Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Lantheus (2019-2024)
Table 60. Lantheus Recent Developments
Table 61. Curium Pharma Basic Information List
Table 62. Curium Pharma Description and Business Overview
Table 63. Curium Pharma Targeted Radionuclide Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Curium Pharma (2019-2024)
Table 65. Curium Pharma Recent Developments
Table 66. Fusion Pharmaceuticals Basic Information List
Table 67. Fusion Pharmaceuticals Description and Business Overview
Table 68. Fusion Pharmaceuticals Targeted Radionuclide Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Fusion Pharmaceuticals (2019-2024)
Table 70. Fusion Pharmaceuticals Recent Developments
Table 71. RadioMedix, Inc. Basic Information List
Table 72. RadioMedix, Inc. Description and Business Overview
Table 73. RadioMedix, Inc. Targeted Radionuclide Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Targeted Radionuclide Drug Business of RadioMedix, Inc. (2019-2024)
Table 75. RadioMedix, Inc. Recent Developments
Table 76. Convergent Therapeutics Basic Information List
Table 77. Convergent Therapeutics Description and Business Overview
Table 78. Convergent Therapeutics Targeted Radionuclide Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Convergent Therapeutics (2019-2024)
Table 80. Convergent Therapeutics Recent Developments
Table 81. IONETIX Basic Information List
Table 82. IONETIX Description and Business Overview
Table 83. IONETIX Targeted Radionuclide Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Targeted Radionuclide Drug Business of IONETIX (2019-2024)
Table 85. IONETIX Recent Developments
Table 86. Clarity Pharmaceuticals Basic Information List
Table 87. Clarity Pharmaceuticals Description and Business Overview
Table 88. Clarity Pharmaceuticals Targeted Radionuclide Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Clarity Pharmaceuticals (2019-2024)
Table 90. Clarity Pharmaceuticals Recent Developments
Table 91. RayzeBio, Inc Basic Information List
Table 92. RayzeBio, Inc Description and Business Overview
Table 93. RayzeBio, Inc Targeted Radionuclide Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Targeted Radionuclide Drug Business of RayzeBio, Inc (2019-2024)
Table 95. RayzeBio, Inc Recent Developments
Table 96. AmbioPharm Basic Information List
Table 97. AmbioPharm Description and Business Overview
Table 98. AmbioPharm Targeted Radionuclide Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Targeted Radionuclide Drug Business of AmbioPharm (2019-2024)
Table 100. AmbioPharm Recent Developments
Table 101. Bracco Imaging Basic Information List
Table 102. Bracco Imaging Description and Business Overview
Table 103. Bracco Imaging Targeted Radionuclide Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Bracco Imaging (2019-2024)
Table 105. Bracco Imaging Recent Developments
Table 106. Navidea Basic Information List
Table 107. Navidea Description and Business Overview
Table 108. Navidea Targeted Radionuclide Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Navidea (2019-2024)
Table 110. Navidea Recent Developments
Table 111. China Isotope & Radiation Corporation Basic Information List
Table 112. China Isotope & Radiation Corporation Description and Business Overview
Table 113. China Isotope & Radiation Corporation Targeted Radionuclide Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Targeted Radionuclide Drug Business of China Isotope & Radiation Corporation (2019-2024)
Table 115. China Isotope & Radiation Corporation Recent Developments
Table 116. Yantai Dongcheng Basic Information List
Table 117. Yantai Dongcheng Description and Business Overview
Table 118. Yantai Dongcheng Targeted Radionuclide Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Yantai Dongcheng (2019-2024)
Table 120. Yantai Dongcheng Recent Developments
Table 121. Grand Pharma Basic Information List
Table 122. Grand Pharma Description and Business Overview
Table 123. Grand Pharma Targeted Radionuclide Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Grand Pharma (2019-2024)
Table 125. Grand Pharma Recent Developments
Table 126. Hengrui Medicine Basic Information List
Table 127. Hengrui Medicine Description and Business Overview
Table 128. Hengrui Medicine Targeted Radionuclide Drug Products, Services and Solutions
Table 129. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Hengrui Medicine (2019-2024)
Table 130. Hengrui Medicine Recent Developments
Table 131. Yunnan Baiyao Group Basic Information List
Table 132. Yunnan Baiyao Group Description and Business Overview
Table 133. Yunnan Baiyao Group Targeted Radionuclide Drug Products, Services and Solutions
Table 134. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Yunnan Baiyao Group (2019-2024)
Table 135. Yunnan Baiyao Group Recent Developments
Table 136. SmartNuclide Biopharma Basic Information List
Table 137. SmartNuclide Biopharma Description and Business Overview
Table 138. SmartNuclide Biopharma Targeted Radionuclide Drug Products, Services and Solutions
Table 139. Revenue (US$ Million) in Targeted Radionuclide Drug Business of SmartNuclide Biopharma (2019-2024)
Table 140. SmartNuclide Biopharma Recent Developments
Table 141. Sinotau Basic Information List
Table 142. Sinotau Description and Business Overview
Table 143. Sinotau Targeted Radionuclide Drug Products, Services and Solutions
Table 144. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Sinotau (2019-2024)
Table 145. Sinotau Recent Developments
Table 146. Hexin Pharmaceutical Basic Information List
Table 147. Hexin Pharmaceutical Description and Business Overview
Table 148. Hexin Pharmaceutical Targeted Radionuclide Drug Products, Services and Solutions
Table 149. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Hexin Pharmaceutical (2019-2024)
Table 150. Hexin Pharmaceutical Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Targeted Radionuclide Drug Downstream Customers
Table 154. Targeted Radionuclide Drug Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Targeted Radionuclide Drug Product Picture
Figure 2. Global Targeted Radionuclide Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Targeted Radionuclide Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Targeted Radionuclide Drug Report Years Considered
Figure 5. Global Targeted Radionuclide Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeted Radionuclide Drug Revenue in 2023
Figure 7. Targeted Radionuclide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Medicine Picture
Figure 9. Inhibitor Picture
Figure 10. Global Targeted Radionuclide Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Targeted Radionuclide Drug Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Tumors
Figure 13. Product Picture of Thyroid
Figure 14. Product Picture of Others
Figure 15. Global Targeted Radionuclide Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Targeted Radionuclide Drug Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Targeted Radionuclide Drug Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Targeted Radionuclide Drug Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Targeted Radionuclide Drug Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Targeted Radionuclide Drug Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Targeted Radionuclide Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Targeted Radionuclide Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Targeted Radionuclide Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Targeted Radionuclide Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Targeted Radionuclide Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Targeted Radionuclide Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Targeted Radionuclide Drug Sales Value (%), (2019-2030)
Figure 28. United States Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 34. China Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 36. China Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. India Targeted Radionuclide Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Targeted Radionuclide Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. India Targeted Radionuclide Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Targeted Radionuclide Drug Industrial Chain
Figure 50. Targeted Radionuclide Drug Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
